Who owns Insmed Inc convertible security?

Tip: Access positions for across all investors

Analyze quarterly positions in Insmed Inc convertible security with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Insmed Inc convertible security stock

Who bought or sold Insmed Inc convertible security this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Deerfield Management Company 117M $124M 7% Dec 2023
 View chart
Braidwell 52M $56M 31% Dec 2023
 View chart
Sonora Investment Management Group 6.1M $6.0M -5% Sep 2023
 View chart
Morgan Stanley 5.7M $5.6M 28% Sep 2023
 View chart
Wolverine Asset Management 4.2M $4.6M 100% Dec 2023
 View chart
Tenor Capital Management 2.9M $3.1B 0% Dec 2023
 View chart
Aequim Alternative Investments 2.3M $2.4M 0% Dec 2023
 View chart
Man Group 2.1M $2.2M 0% Dec 2023
 View chart
Bnp Paribas Investment Partners 2.0M $2.1M 0% Dec 2023
 View chart
Macquarie Group 1.3M $1.3M 0% Sep 2023
 View chart
Kohlberg Kravis Roberts & Co 1.2M $1.3M 50% Dec 2023
 View chart
State Street Corporation 1.0M $1.0M 41% Sep 2023
 View chart
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 1.0M $1.1M 0% Dec 2023
 View chart
Sycale Advisors 590k $585k 0% Sep 2023
 View chart
Amundi 510k $531k -96% Dec 2023
 View chart
Citigroup 155k $165k 0% Dec 2023
 View chart
Bnp Paribas Arbitrage, Snc 12k $13k 0% Dec 2023
 View chart
Patron Partners Advisors 10k $11k 0% Dec 2023
 View chart
Royal Bank of Canada 4.0k $4.0k 0% Dec 2023
 View chart
Wells Fargo & Company 1.0k $1.0k 0% Dec 2023
 View chart

Who sold out of Insmed Inc convertible security?

Fund or Company Name Date Sold Shares Held Valued At
FMR Jun 2023 3.8M $3.5M
Invesco Jun 2023 3.3M $3.1M
Citadel Advisors Sep 2023 2.0M $2.0M
Monashee Investment Management Sep 2023 575k $571k
Jpmorgan Chase & Co Sep 2023 431k $429k
Barclays Sep 2023 84k $82k